-
2
-
-
78951481494
-
Galectin-3 expression: A useful tool in the differential diagnosis of posterior fossa tumors in children
-
Borges CB, Bernardes ES, Latorraca EF, Becker AP, Neder L, Chammas R, Roque-Barreira MC, Machado HR, de Oliveira RS 2010. Galectin-3 expression: A useful tool in the differential diagnosis of posterior fossa tumors in children. Child's Nerv Syst. 27: 253-257.
-
(2010)
Child's Nerv Syst.
, vol.27
, pp. 253-257
-
-
Borges, C.B.1
Bernardes, E.S.2
Latorraca, E.F.3
Becker, A.P.4
Neder, L.5
Chammas, R.6
Roque-Barreira, M.C.7
Machado, H.R.8
De Oliveira, R.S.9
-
3
-
-
0030872450
-
Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system
-
Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A. 1997. Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer. 80: 776-787.
-
(1997)
Cancer
, vol.80
, pp. 776-787
-
-
Bresalier, R.S.1
Yan, P.S.2
Byrd, J.C.3
Lotan, R.4
Raz, A.5
-
4
-
-
33745575716
-
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup radiation therapy oncology group trial 9402
-
Cairncross G, Berkey B, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperierre N, et al. 2006. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol. 24: 2707-2714.
-
(2006)
J Clin Oncol.
, vol.24
, pp. 2707-2714
-
-
Cairncross, G.1
Berkey, B.2
Shaw, E.3
Jenkins, R.4
Scheithauer, B.5
Brachman, D.6
Buckner, J.7
Fink, K.8
Souhami, L.9
Laperierre, N.10
-
5
-
-
6344261571
-
Dual activities of galectin-3 in human prostate cancer: Tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3
-
Califice S, Castronovo V, Bracke M, van den Brule F. 2004. Dual activities of galectin-3 in human prostate cancer: Tumor suppression of nuclear galectin-3 vs tumor promotion of cytoplasmic galectin-3. Oncogene. 23: 7527-7536.
-
(2004)
Oncogene.
, vol.23
, pp. 7527-7536
-
-
Califice, S.1
Castronovo, V.2
Bracke, M.3
Van Den Brule, F.4
-
6
-
-
0035194504
-
Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration
-
Camby I, Belot N, Rorive S, Lefranc F, Maurage CA, Lahm H, Kaltner H, Hadari Y, Ruchoux MM, Brotchi J, et al. 2001. Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. Brain Pathol. 11: 12-26.
-
(2001)
Brain Pathol.
, vol.11
, pp. 12-26
-
-
Camby, I.1
Belot, N.2
Rorive, S.3
Lefranc, F.4
Maurage, C.A.5
Lahm, H.6
Kaltner, H.7
Hadari, Y.8
Ruchoux, M.M.9
Brotchi, J.10
-
8
-
-
0141814720
-
Endothelial cell diversity revealed by global expression profiling
-
Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, et al. 2003. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA. 100: 10623-10628.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 10623-10628
-
-
Chi, J.T.1
Chang, H.Y.2
Haraldsen, G.3
Jahnsen, F.L.4
Troyanskaya, O.G.5
Chang, D.S.6
Wang, Z.7
Rockson, S.G.8
Van De Rijn, M.9
Botstein, D.10
-
9
-
-
84894194756
-
Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma
-
Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea D, et al. 2014. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med. 370: 709-722.
-
(2014)
N Engl J Med.
, vol.370
, pp. 709-722
-
-
Chinot, O.L.1
Wick, W.2
Mason, W.3
Henriksson, R.4
Saran, F.5
Nishikawa, R.6
Carpentier, A.F.7
Hoang-Xuan, K.8
Kavan, P.9
Cernea, D.10
-
10
-
-
2242463023
-
Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion
-
Clausse N, van den Brule F, Waltregny D, Garnier F, Castronovo V. 1999. Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion. Angiogenesis. 3: 317-325.
-
(1999)
Angiogenesis.
, vol.3
, pp. 317-325
-
-
Clausse, N.1
Van Den Brule, F.2
Waltregny, D.3
Garnier, F.4
Castronovo, V.5
-
11
-
-
84894136530
-
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors
-
Croci DO, Cerliani JP, Dalotto-Moreno T, Mendez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, Toscano MA, Caramelo JJ, Garcia-Vallejo JJ, Ouyang J, et al. 2014. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell. 156: 744-758.
-
(2014)
Cell
, vol.156
, pp. 744-758
-
-
Croci, D.O.1
Cerliani, J.P.2
Dalotto-Moreno, T.3
Mendez-Huergo, S.P.4
Mascanfroni, I.D.5
Dergan-Dylon, S.6
Toscano, M.A.7
Caramelo, J.J.8
Garcia-Vallejo, J.J.9
Ouyang, J.10
-
12
-
-
84870279245
-
Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in kaposi's sarcoma
-
Croci DO, Salatino M, Rubinstein N, Cerliani JP, Cavallin LE, Leung HJ, Ouyang J, Ilarregui JM, Toscano MA, Domaica CI, et al. 2012. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. J Exp Med. 209: 1985-2000.
-
(2012)
J Exp Med.
, vol.209
, pp. 1985-2000
-
-
Croci, D.O.1
Salatino, M.2
Rubinstein, N.3
Cerliani, J.P.4
Cavallin, L.E.5
Leung, H.J.6
Ouyang, J.7
Ilarregui, J.M.8
Toscano, M.A.9
Domaica, C.I.10
-
13
-
-
38349116205
-
Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas
-
D'Haene N, Catteau X, Maris C, Martin B, Salmon I, Decaestecker C. 2008. Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas. Br J Haematol. 140: 402-410.
-
(2008)
Br J Haematol.
, vol.140
, pp. 402-410
-
-
D'Haene, N.1
Catteau, X.2
Maris, C.3
Martin, B.4
Salmon, I.5
Decaestecker, C.6
-
14
-
-
27444435035
-
The differential expression of galectin-1 and galectin-3 in normal lymphoid tissue and non-hodgkin's and hodgkin's lymphomas
-
D'Haene N, Maris C, Sandras F, Dehou MF, Remmelink M, Decaestecker C, Salmon I. 2005. The differential expression of galectin-1 and galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas. Int J Immunopathol Pharmacol. 18: 431-443.
-
(2005)
Int J Immunopathol Pharmacol.
, vol.18
, pp. 431-443
-
-
D'Haene, N.1
Maris, C.2
Sandras, F.3
Dehou, M.F.4
Remmelink, M.5
Decaestecker, C.6
Salmon, I.7
-
15
-
-
84879174123
-
VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis
-
D'Haene N, Sauvage S, Maris C, Adanja I, Le Mercier M, Decaestecker C, Baum L, Salmon I. 2013. VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis. PLoS ONE. 8: e67029.
-
(2013)
PLoS ONE
, vol.8
-
-
D'Haene, N.1
Sauvage, S.2
Maris, C.3
Adanja, I.4
Le Mercier, M.5
Decaestecker, C.6
Baum, L.7
Salmon, I.8
-
16
-
-
0036330138
-
Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients
-
Deininger MH, Trautmann K, Meyermann R, Schluesener HJ. 2002. Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients. Anticancer Res. 22: 1585-1592.
-
(2002)
Anticancer Res.
, vol.22
, pp. 1585-1592
-
-
Deininger, M.H.1
Trautmann, K.2
Meyermann, R.3
Schluesener, H.J.4
-
17
-
-
42949120441
-
The galectin family and digestive disease
-
Demetter P, Nagy N, Martin B, Mathieu A, Dumont P, Decaestecker C, Salmon I. 2008. The galectin family and digestive disease. J Pathol. 215: 1-12.
-
(2008)
J Pathol.
, vol.215
, pp. 1-12
-
-
Demetter, P.1
Nagy, N.2
Martin, B.3
Mathieu, A.4
Dumont, P.5
Decaestecker, C.6
Salmon, I.7
-
18
-
-
66849099801
-
Activation of the ERK/MAPK pathway: A signature genetic defect in posterior fossa pilocytic astrocytomas
-
Forshew T, Tatevossian RG, Lawson AR, Ma J, Neale G, Ogunkolade BW, Jones TA, Aarum J, Dalton J, Bailey S, et al. 2009. Activation of the ERK/MAPK pathway: A signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol. 218: 172-181.
-
(2009)
J Pathol.
, vol.218
, pp. 172-181
-
-
Forshew, T.1
Tatevossian, R.G.2
Lawson, A.R.3
Ma, J.4
Neale, G.5
Ogunkolade, B.W.6
Jones, T.A.7
Aarum, J.8
Dalton, J.9
Bailey, S.10
-
19
-
-
84894114159
-
A randomized trial of bevacizumab for newly diagnosed glioblastoma
-
Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, et al. 2014. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 370: 699-708.
-
(2014)
N Engl J Med.
, vol.370
, pp. 699-708
-
-
Gilbert, M.R.1
Dignam, J.J.2
Armstrong, T.S.3
Wefel, J.S.4
Blumenthal, D.T.5
Vogelbaum, M.A.6
Colman, H.7
Chakravarti, A.8
Pugh, S.9
Won, M.10
-
20
-
-
0032813082
-
Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis
-
Gordower L, Decaestecker C, Kacem Y, Lemmers A, Gusman J, Burchert M, Danguy A, Gabius H, Salmon I, Kiss R, et al. 1999. Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropathol Appl Neurobiol. 25: 319-330.
-
(1999)
Neuropathol Appl Neurobiol.
, vol.25
, pp. 319-330
-
-
Gordower, L.1
Decaestecker, C.2
Kacem, Y.3
Lemmers, A.4
Gusman, J.5
Burchert, M.6
Danguy, A.7
Gabius, H.8
Salmon, I.9
Kiss, R.10
-
21
-
-
21344438419
-
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1)
-
Greijer AE, van der Groep P, Kemming D, Shvarts A, Semenza GL, Meijer GA, van de Wiel MA, Belien JA, van Diest PJ, van der Wall E. 2005. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol. 206: 291-304.
-
(2005)
J Pathol.
, vol.206
, pp. 291-304
-
-
Greijer, A.E.1
Van Der Groep, P.2
Kemming, D.3
Shvarts, A.4
Semenza, G.L.5
Meijer, G.A.6
Van De Wiel, M.A.7
Belien, J.A.8
Van Diest, P.J.9
Van Der Wall, E.10
-
22
-
-
84866510711
-
Mechanisms of glioma-associated neovascularization
-
Hardee ME, Zagzag D. 2012. Mechanisms of glioma-associated neovascularization. Am J Pathol. 181: 1126-1141.
-
(2012)
Am J Pathol.
, vol.181
, pp. 1126-1141
-
-
Hardee, M.E.1
Zagzag, D.2
-
23
-
-
45949085841
-
Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells
-
Hsieh SH, Ying NW, Wu MH, Chiang WF, Hsu CL, Wong TY, Jin YT, Hong TM, Chen YL. 2008. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene. 27: 3746-3753.
-
(2008)
Oncogene.
, vol.27
, pp. 3746-3753
-
-
Hsieh, S.H.1
Ying, N.W.2
Wu, M.H.3
Chiang, W.F.4
Hsu, C.L.5
Wong, T.Y.6
Jin, Y.T.7
Hong, T.M.8
Chen, Y.L.9
-
25
-
-
84907207296
-
Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer
-
Huang CS, Tang SJ, Chung LY, Yu CP, Ho JY, Cha TL, Hsieh CC, Wang HH, Sun GH, Sun KH. 2014. Galectin-1 upregulates CXCR4 to promote tumor progression and poor outcome in kidney cancer. J Am Soc Nephrol. doi: 10.1681/ASN.2013070773.
-
(2014)
J Am Soc Nephrol.
-
-
Huang, C.S.1
Tang, S.J.2
Chung, L.Y.3
Yu, C.P.4
Ho, J.Y.5
Cha, T.L.6
Hsieh, C.C.7
Wang, H.H.8
Sun, G.H.9
Sun, K.H.10
-
26
-
-
76749123529
-
Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE
-
Jia J, Wang J, Teh M, Sun W, Zhang J, Kee I, Chow PK, Liang RC, Chung MC, Ge R. 2010. Identification of proteins differentially expressed between capillary endothelial cells of hepatocellular carcinoma and normal liver in an orthotopic rat tumor model using 2-D DIGE. Proteomics. 10: 224-234.
-
(2010)
Proteomics.
, vol.10
, pp. 224-234
-
-
Jia, J.1
Wang, J.2
Teh, M.3
Sun, W.4
Zhang, J.5
Kee, I.6
Chow, P.K.7
Liang, R.C.8
Chung, M.C.9
Ge, R.10
-
27
-
-
84871983882
-
A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease
-
Laderach DJ, Gentilini LD, Giribaldi L, Delgado VC, Nugnes L, Croci DO, Al Nakouzi N, Sacca P, Casas G, Mazza O, et al. 2013. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. Cancer Res. 73: 86-96.
-
(2013)
Cancer Res.
, vol.73
, pp. 86-96
-
-
Laderach, D.J.1
Gentilini, L.D.2
Giribaldi, L.3
Delgado, V.C.4
Nugnes, L.5
Croci, D.O.6
Al Nakouzi, N.7
Sacca, P.8
Casas, G.9
Mazza, O.10
-
28
-
-
71549114583
-
Galectins and gliomas
-
Le Mercier M, Fortin S, Mathieu V, Kiss R, Lefranc F. 2010. Galectins and gliomas. Brain Pathol. 20: 17-27.
-
(2010)
Brain Pathol.
, vol.20
, pp. 17-27
-
-
Le Mercier, M.1
Fortin, S.2
Mathieu, V.3
Kiss, R.4
Lefranc, F.5
-
29
-
-
65949100404
-
Galectin 1 proangiogenic and promigratory effects in the hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression
-
Le Mercier M, Fortin S, Mathieu V, Roland I, Spiegl-Kreinecker S, Haibe-Kains B, Bontempi G, Decaestecker C, Berger W, Lefranc F, et al. 2009. Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia. 11: 485-496.
-
(2009)
Neoplasia.
, vol.11
, pp. 485-496
-
-
Le Mercier, M.1
Fortin, S.2
Mathieu, V.3
Roland, I.4
Spiegl-Kreinecker, S.5
Haibe-Kains, B.6
Bontempi, G.7
Decaestecker, C.8
Berger, W.9
Lefranc, F.10
-
30
-
-
84866507582
-
A simplified approach for the molecular classification of glioblastomas
-
Le Mercier M, Hastir D, Moles Lopez X, De Neve N, Maris C, Trepant AL, Rorive S, Decaestecker C, Salmon I. 2012. A simplified approach for the molecular classification of glioblastomas. PLoS ONE. 7: e45475.
-
(2012)
PLoS ONE
, vol.7
-
-
Le Mercier, M.1
Hastir, D.2
Moles Lopez, X.3
De Neve, N.4
Maris, C.5
Trepant, A.L.6
Rorive, S.7
Decaestecker, C.8
Salmon, I.9
-
31
-
-
43249107550
-
Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses
-
Le Mercier M, Mathieu V, Haibe-Kains B, Bontempi G, Mijatovic T, Decaestecker C, Kiss R, Lefranc F. 2008. Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. J Neuropathol Exp Neurol. 67: 456-469.
-
(2008)
J Neuropathol Exp Neurol.
, vol.67
, pp. 456-469
-
-
Le Mercier, M.1
Mathieu, V.2
Haibe-Kains, B.3
Bontempi, G.4
Mijatovic, T.5
Decaestecker, C.6
Kiss, R.7
Lefranc, F.8
-
32
-
-
33144460217
-
Galectin-1: A link between tumor hypoxia and tumor immune privilege
-
Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O'Byrne KJ, et al. 2005. Galectin-1: A link between tumor hypoxia and tumor immune privilege. J Clin Oncol. 23: 8932-8941.
-
(2005)
J Clin Oncol.
, vol.23
, pp. 8932-8941
-
-
Le, Q.T.1
Shi, G.2
Cao, H.3
Nelson, D.W.4
Wang, Y.5
Chen, E.Y.6
Zhao, S.7
Kong, C.8
Richardson, D.9
O'Byrne, K.J.10
-
33
-
-
77953405595
-
Differentiation of the brain vasculature: The answer came blowing by the wnt
-
Liebner S, Plate KH. 2010. Differentiation of the brain vasculature: The answer came blowing by the Wnt. J Angiogenesis Res. 2: 1.
-
(2010)
J Angiogenesis Res.
, vol.2
, pp. 1
-
-
Liebner, S.1
Plate, K.H.2
-
34
-
-
11144241063
-
Galectins as modulators of tumour progression
-
Liu FT, Rabinovich GA. 2005. Galectins as modulators of tumour progression. Nat Rev Cancer. 5: 29-41.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 29-41
-
-
Liu, F.T.1
Rabinovich, G.A.2
-
35
-
-
80051612685
-
Clinical development of vascular disrupting agents: What lessons can we learn from ASA404?
-
LoRusso PM, Boerner SA, Hunsberger S. 2011. Clinical development of vascular disrupting agents: What lessons can we learn from ASA404? J Clin Oncol. 29: 2952-2955.
-
(2011)
J Clin Oncol.
, vol.29
, pp. 2952-2955
-
-
LoRusso, P.M.1
Boerner, S.A.2
Hunsberger, S.3
-
36
-
-
0028097127
-
Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion
-
Lotan R, Belloni PN, Tressler RJ, Lotan D, Xu XC, Nicolson GL. 1994. Expression of galectins on microvessel endothelial cells and their involvement in tumour cell adhesion. Glycoconj J. 11: 462-468.
-
(1994)
Glycoconj J.
, vol.11
, pp. 462-468
-
-
Lotan, R.1
Belloni, P.N.2
Tressler, R.J.3
Lotan, D.4
Xu, X.C.5
Nicolson, G.L.6
-
38
-
-
1242269809
-
Genetic dissection of tumor angiogenesis: Are PlGF and VEGFR-1 novel anti-cancer targets?
-
Luttun A, Autiero M, Tjwa M, Carmeliet P. 2004. Genetic dissection of tumor angiogenesis: Are PlGF and VEGFR-1 novel anti-cancer targets? Biochim Biophys Acta. 1654: 79-94.
-
(2004)
Biochim Biophys Acta
, vol.1654
, pp. 79-94
-
-
Luttun, A.1
Autiero, M.2
Tjwa, M.3
Carmeliet, P.4
-
39
-
-
84904610688
-
Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFbeta1-induced macrophages
-
Machado CM, Andrade LN, Teixeira VR, Costa FF, Melo CM, Dos Santos SN, Nonogaki S, Liu FT, Bernardes ES, Camargo AA, et al. 2014. Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFbeta1-induced macrophages. Cancer Med. 3: 201-214.
-
(2014)
Cancer Med.
, vol.3
, pp. 201-214
-
-
Machado, C.M.1
Andrade, L.N.2
Teixeira, V.R.3
Costa, F.F.4
Melo, C.M.5
Dos Santos, S.N.6
Nonogaki, S.7
Liu, F.T.8
Bernardes, E.S.9
Camargo, A.A.10
-
40
-
-
42549129386
-
Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas
-
Maris C, Rorive S, Sandras F, D'Haene N, Sadeghi N, Bieche I, Vidaud M, Decaestecker C, Salmon I. 2008. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Neuropathol Appl Neurobiol. 34: 316-329.
-
(2008)
Neuropathol Appl Neurobiol.
, vol.34
, pp. 316-329
-
-
Maris, C.1
Rorive, S.2
Sandras, F.3
D'Haene, N.4
Sadeghi, N.5
Bieche, I.6
Vidaud, M.7
Decaestecker, C.8
Salmon, I.9
-
41
-
-
80051930613
-
Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells
-
Markowska AI, Jefferies KC, Panjwani N. 2011. Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J Biol Chem. 286: 29913-29921.
-
(2011)
J Biol Chem.
, vol.286
, pp. 29913-29921
-
-
Markowska, A.I.1
Jefferies, K.C.2
Panjwani, N.3
-
42
-
-
77956233662
-
Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
-
Markowska AI, Liu FT, Panjwani N. 2010. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med. 207: 1981-1993.
-
(2010)
J Exp Med.
, vol.207
, pp. 1981-1993
-
-
Markowska, A.I.1
Liu, F.T.2
Panjwani, N.3
-
43
-
-
84883556394
-
Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas
-
Mascelli S, Barla A, Raso A, Mosci S, Nozza P, Biassoni R, Morana G, Huber M, Mircean C, Fasulo D, et al. 2013. Molecular fingerprinting reflects different histotypes and brain region in low grade gliomas. BMC Cancer. 13: 387.
-
(2013)
BMC Cancer
, vol.13
, pp. 387
-
-
Mascelli, S.1
Barla, A.2
Raso, A.3
Mosci, S.4
Nozza, P.5
Biassoni, R.6
Morana, G.7
Huber, M.8
Mircean, C.9
Fasulo, D.10
-
44
-
-
84865309693
-
Galectin-1 in melanoma biology and related neo-angiogenesis processes
-
Mathieu V, de Lassalle EM, Toelen J, Mohr T, Bellahcene A, Van Goietsenoven G, Verschuere T, Bouzin C, Debyser Z, De Vleeschouwer S, et al. 2012. Galectin-1 in melanoma biology and related neo-angiogenesis processes. J Invest Dermatol. 132: 2245-2254.
-
(2012)
J Invest Dermatol.
, vol.132
, pp. 2245-2254
-
-
Mathieu, V.1
De Lassalle, E.M.2
Toelen, J.3
Mohr, T.4
Bellahcene, A.5
Van Goietsenoven, G.6
Verschuere, T.7
Bouzin, C.8
Debyser, Z.9
De Vleeschouwer, S.10
-
45
-
-
0033888016
-
Galectin-3 induces endothelial cell morphogenesis and angiogenesis
-
Nangia-Makker P, Honjo Y, Sarvis R, Akahani S, Hogan V, Pienta KJ, Raz A. 2000. Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am J Pathol. 156: 899-909.
-
(2000)
Am J Pathol.
, vol.156
, pp. 899-909
-
-
Nangia-Makker, P.1
Honjo, Y.2
Sarvis, R.3
Akahani, S.4
Hogan, V.5
Pienta, K.J.6
Raz, A.7
-
46
-
-
8744224531
-
Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas
-
Neder L, Marie SK, Carlotti CG, Jr, Gabbai AA, Rosemberg S, Malheiros SM, Siqueira RP, Oba-Shinjo SM, Uno M, Aguiar PH, et al. 2004. Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas. Brain Pathol. 14: 399-405.
-
(2004)
Brain Pathol.
, vol.14
, pp. 399-405
-
-
Neder, L.1
Marie, S.K.2
Carlotti, C.G.3
Gabbai, A.A.4
Rosemberg, S.5
Malheiros, S.M.6
Siqueira, R.P.7
Oba-Shinjo, S.M.8
Uno, M.9
Aguiar, P.H.10
-
47
-
-
82655173829
-
Galectin-3 - A jack-of-all-trades in cancer
-
Newlaczyl AU, Yu LG. 2011. Galectin-3 - a jack-of-all-trades in cancer. Cancer Lett. 313: 123-128.
-
(2011)
Cancer Lett.
, vol.313
, pp. 123-128
-
-
Newlaczyl, A.U.1
Yu, L.G.2
-
48
-
-
71349083949
-
In pursuit of prognostic factors in children with pilocytic astrocytomas
-
Paixao Becker A, de Oliveira RS, Saggioro FP, Neder L, Chimelli LM, Machado HR. 2010. In pursuit of prognostic factors in children with pilocytic astrocytomas. Childs Nerv Syst. 26: 19-28.
-
(2010)
Childs Nerv Syst.
, vol.26
, pp. 19-28
-
-
Paixao Becker, A.1
De Oliveira, R.S.2
Saggioro, F.P.3
Neder, L.4
Chimelli, L.M.5
Machado, H.R.6
-
49
-
-
49749137921
-
Galectin-3: A useful biomarker for differential diagnosis of brain tumors
-
Park SH, Min HS, Kim B, Myung J, Paek SH. 2008. Galectin-3: A useful biomarker for differential diagnosis of brain tumors. Neuropathology. 28: 497-506.
-
(2008)
Neuropathology
, vol.28
, pp. 497-506
-
-
Park, S.H.1
Min, H.S.2
Kim, B.3
Myung, J.4
Paek, S.H.5
-
50
-
-
18044374479
-
Galectin-1 as a potential cancer target
-
Rabinovich GA 2005. Galectin-1 as a potential cancer target. Br J Cancer. 92: 1188-1192.
-
(2005)
Br J Cancer
, vol.92
, pp. 1188-1192
-
-
Rabinovich, G.A.1
-
51
-
-
0035107949
-
Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma
-
Rorive S, Belot N, Decaestecker C, Lefranc F, Gordower L, Micik S, Maurage CA, Kaltner H, Ruchoux MM, Danguy A, et al. 2001. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma. Glia. 33: 241-255.
-
(2001)
Glia.
, vol.33
, pp. 241-255
-
-
Rorive, S.1
Belot, N.2
Decaestecker, C.3
Lefranc, F.4
Gordower, L.5
Micik, S.6
Maurage, C.A.7
Kaltner, H.8
Ruchoux, M.M.9
Danguy, A.10
-
52
-
-
77957602528
-
TIMP-4 and CD63: New prognostic biomarkers in human astrocytomas
-
Rorive S, Lopez XM, Maris C, Trepant AL, Sauvage S, Sadeghi N, Roland I, Decaestecker C, Salmon I. 2010. TIMP-4 and CD63: New prognostic biomarkers in human astrocytomas. Mod Pathol. 23: 1418-1428.
-
(2010)
Mod Pathol.
, vol.23
, pp. 1418-1428
-
-
Rorive, S.1
Lopez, X.M.2
Maris, C.3
Trepant, A.L.4
Sauvage, S.5
Sadeghi, N.6
Roland, I.7
Decaestecker, C.8
Salmon, I.9
-
53
-
-
27144539890
-
Human galectin-2: Expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization
-
Saal I, Nagy N, Lensch M, Lohr M, Manning JC, Decaestecker C, Andre S, Kiss R, Salmon I, Gabius HJ. 2005. Human galectin-2: Expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. Histol Histopathol. 20: 1191-1208.
-
(2005)
Histol Histopathol.
, vol.20
, pp. 1191-1208
-
-
Saal, I.1
Nagy, N.2
Lensch, M.3
Lohr, M.4
Manning, J.C.5
Decaestecker, C.6
Andre, S.7
Kiss, R.8
Salmon, I.9
Gabius, H.J.10
-
54
-
-
70249097408
-
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas
-
Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, El Hallani S, Boisselier B, Mokhtari K, Hoang-Xuan K, et al. 2009. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol. 27: 4150-4154.
-
(2009)
J Clin Oncol.
, vol.27
, pp. 4150-4154
-
-
Sanson, M.1
Marie, Y.2
Paris, S.3
Idbaih, A.4
Laffaire, J.5
Ducray, F.6
El Hallani, S.7
Boisselier, B.8
Mokhtari, K.9
Hoang-Xuan, K.10
-
55
-
-
0034682892
-
Genes expressed in human tumor endothelium
-
St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, et al. 2000. Genes expressed in human tumor endothelium. Science. 289: 1197-1202.
-
(2000)
Science
, vol.289
, pp. 1197-1202
-
-
St Croix, B.1
Rago, C.2
Velculescu, V.3
Traverso, G.4
Romans, K.E.5
Montgomery, E.6
Lal, A.7
Riggins, G.J.8
Lengauer, C.9
Vogelstein, B.10
-
56
-
-
80052362586
-
Increased expression of distinct galectins in multiple sclerosis lesions
-
Stancic M, van Horssen J, Thijssen VL, Gabius HJ, van der Valk P, Hoekstra D, Baron W. 2011. Increased expression of distinct galectins in multiple sclerosis lesions. Neuropathol Appl Neurobiol. 37: 654-671.
-
(2011)
Neuropathol Appl Neurobiol.
, vol.37
, pp. 654-671
-
-
Stancic, M.1
Van Horssen, J.2
Thijssen, V.L.3
Gabius, H.J.4
Van Der Valk, P.5
Hoekstra, D.6
Baron, W.7
-
57
-
-
17544373394
-
New roles for galectins in brain tumors - From prognostic markers to therapeutic targets
-
Stillman BN, Mischel PS, Baum LG. 2005. New roles for galectins in brain tumors - from prognostic markers to therapeutic targets. Brain Pathol. 15: 124-132.
-
(2005)
Brain Pathol.
, vol.15
, pp. 124-132
-
-
Stillman, B.N.1
Mischel, P.S.2
Baum, L.G.3
-
58
-
-
0034784518
-
Galectin-3: Cellular distribution and correlation with WHO-grade in human gliomas
-
Strik HM, Deininger MH, Frank B, Schluesener HJ, Meyermann R. 2001. Galectin-3: Cellular distribution and correlation with WHO-grade in human gliomas. J Neurooncol. 53: 13-20.
-
(2001)
J Neurooncol.
, vol.53
, pp. 13-20
-
-
Strik, H.M.1
Deininger, M.H.2
Frank, B.3
Schluesener, H.J.4
Meyermann, R.5
-
59
-
-
0033765275
-
Adhesive and invasive features in gliomas
-
Tews DS 2000. Adhesive and invasive features in gliomas. Pathol Res Pract. 196: 701-711.
-
(2000)
Pathol Res Pract.
, vol.196
, pp. 701-711
-
-
Tews, D.S.1
-
60
-
-
77955347056
-
Tumor cells secrete galectin-1 to enhance endothelial cell activity
-
Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, Hackeng TM, Kiss R, Kloog Y, Poirier F, et al. 2010. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res. 70: 6216-6224.
-
(2010)
Cancer Res.
, vol.70
, pp. 6216-6224
-
-
Thijssen, V.L.1
Barkan, B.2
Shoji, H.3
Aries, I.M.4
Mathieu, V.5
Deltour, L.6
Hackeng, T.M.7
Kiss, R.8
Kloog, Y.9
Poirier, F.10
-
61
-
-
35549003245
-
Galectins in the tumor endothelium: Opportunities for combined cancer therapy
-
Thijssen VL, Poirier F, Baum LG, Griffioen AW. 2007. Galectins in the tumor endothelium: Opportunities for combined cancer therapy. Blood. 110: 2819-2827.
-
(2007)
Blood
, vol.110
, pp. 2819-2827
-
-
Thijssen, V.L.1
Poirier, F.2
Baum, L.G.3
Griffioen, A.W.4
-
62
-
-
33750474852
-
Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy
-
Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, et al. 2006. Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci USA. 103: 15975-15980.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 15975-15980
-
-
Thijssen, V.L.1
Postel, R.2
Brandwijk, R.J.3
Dings, R.P.4
Nesmelova, I.5
Satijn, S.6
Verhofstad, N.7
Nakabeppu, Y.8
Baum, L.G.9
Bakkers, J.10
-
63
-
-
0343962593
-
Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression
-
van den Brule FA, Waltregny D, Liu FT, Castronovo V. 2000. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer. 89: 361-367.
-
(2000)
Int J Cancer
, vol.89
, pp. 361-367
-
-
Van Den Brule, F.A.1
Waltregny, D.2
Liu, F.T.3
Castronovo, V.4
-
64
-
-
84890126632
-
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
-
Verschuere T, Toelen J, Maes W, Poirier F, Boon L, Tousseyn T, Mathivet T, Gerhardt H, Mathieu V, Kiss R, et al. 2014. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity. Int J Cancer. 134: 873-884.
-
(2014)
Int J Cancer
, vol.134
, pp. 873-884
-
-
Verschuere, T.1
Toelen, J.2
Maes, W.3
Poirier, F.4
Boon, L.5
Tousseyn, T.6
Mathivet, T.7
Gerhardt, H.8
Mathieu, V.9
Kiss, R.10
-
65
-
-
84885475418
-
Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
-
Verschuere T, Van Woensel M, Fieuws S, Lefranc F, Mathieu V, Kiss R, Van Gool SW, De Vleeschouwer S. 2013. Altered galectin-1 serum levels in patients diagnosed with high-grade glioma. J Neurooncol. 115: 9-17.
-
(2013)
J Neurooncol.
, vol.115
, pp. 9-17
-
-
Verschuere, T.1
Van Woensel, M.2
Fieuws, S.3
Lefranc, F.4
Mathieu, V.5
Kiss, R.6
Van Gool, S.W.7
De Vleeschouwer, S.8
-
66
-
-
0034653127
-
Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells
-
Yamaoka K, Mishima K, Nagashima Y, Asai A, Sanai Y, Kirino T. 2000. Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. J Neurosci Res. 59: 722-730.
-
(2000)
J Neurosci Res.
, vol.59
, pp. 722-730
-
-
Yamaoka, K.1
Mishima, K.2
Nagashima, Y.3
Asai, A.4
Sanai, Y.5
Kirino, T.6
-
67
-
-
38749107818
-
HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc
-
Zeng Y, Danielson KG, Albert TJ, Shapiro IM, Risbud MV. 2007. HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc. J Bone Miner Res. 22: 1851-1861.
-
(2007)
J Bone Miner Res.
, vol.22
, pp. 1851-1861
-
-
Zeng, Y.1
Danielson, K.G.2
Albert, T.J.3
Shapiro, I.M.4
Risbud, M.V.5
|